Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

2.54
+1.1785.40%
Pre-market: 2.26-0.2800-11.02%06:47 EDT
Volume:82.68M
Turnover:169.14M
Market Cap:15.38M
PE:-0.21
High:2.75
Open:1.72
Low:1.58
Close:1.37
Loading ...

BioXcel Therapeutics initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
19 Mar

Why BioXcel Therapeutics, Inc. (BTAI) Soared Last Week

Insider Monkey
·
10 Mar

BioXcel Therapeutics Climbs After Enrollment Update in Drug Trial

Dow Jones
·
08 Mar

BioXcel Therapeutics Inc expected to post a loss of $6.38 a share - Earnings Preview

Reuters
·
07 Mar

BioXcel Therapeutics announces 33% enrollment in SERENTIY at-home Phase 3 trial

TIPRANKS
·
07 Mar

BRIEF-Bioxcel Therapeutics Announces 33% Enrollment In Serenity At-Home Pivotal Phase 3 Safety Trial

Reuters
·
07 Mar

ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
05 Mar

BRIEF-Bioxcel Therapeutics Announces Closing Of $14 Million Registered Direct Offering

Reuters
·
05 Mar

BioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zacks
·
04 Mar

Press Release: BioXcel Therapeutics Announces $14 Million Registered Direct Offering

Dow Jones
·
04 Mar

Top Midday Gainers

MT Newswires Live
·
04 Mar

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
01 Mar

BioXcel Therapeutics Regains Nasdaq Compliance

MT Newswires Live
·
28 Feb

Wall Street Set to Open Higher Friday as Inflation Data Meets Expectations

MT Newswires Live
·
28 Feb

US Stock Futures Rise as Investors Await Key Inflation Data

MT Newswires Live
·
28 Feb

Top Premarket Gainers

MT Newswires Live
·
28 Feb

BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire
·
28 Feb

BioXcel to Implement Reverse Stock Split; Shares Fall

MT Newswires Live
·
07 Feb

BioXcel Therapeutics Announces Reverse Stock Split

GlobeNewswire
·
06 Feb